DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MLN-591RL
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MLN-591RL
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
F-18-ISO
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
F-18-ISO
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9191
1
Small molecule
Investigational
Unknown
Unknown
Condylomata Acuminata
Unknown
GS-9191
×
Maximum Phase:
1
First Approval:
None
UNII:
5I2GJW5Z2Q
Molecule Type:
Small molecule
Molecular Formula:
C37H51N8O6P
Molecular Weight:
734.84
AlogP:
4.95
PSA:
184.61
HBD:
4.0
HBA:
#RotB:
21.0
Source:
YTTRIUM Y 90 EPRATUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
CD22 binding agent
YTTRIUM Y 90 EPRATUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ITOLIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Asthma; Graft vs Host Disease; Severe Acute Respiratory Syndrome
T-cell differentiation antigen CD6 inhibitor
ITOLIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
XQQ2RHV14N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAMPARIB
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
ATAMPARIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
177LU-ST2210
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
177LU-ST2210
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2-DEOXY-D-GLUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
2-DEOXY-D-GLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MEDI-4276
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-4276
×
Maximum Phase:
1
First Approval:
None
UNII:
ZAM3L34SEW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06273340
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06273340
×
Maximum Phase:
1
First Approval:
None
UNII:
I136775ABW
Molecule Type:
Small molecule
Molecular Formula:
C23H22ClN7O3
Molecular Weight:
479.93
AlogP:
2.6
PSA:
148.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RG-7594
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RG-7594
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MK-6186
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
MK-6186
×
Maximum Phase:
1
First Approval:
None
UNII:
K3978U665M
Molecule Type:
Small molecule
Molecular Formula:
C21H12Cl2N6O
Molecular Weight:
435.27
AlogP:
5.33
PSA:
92.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IODOMETOMIDATE I-123, R-
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IODOMETOMIDATE I-123, R-
×
Maximum Phase:
1
First Approval:
None
UNII:
U21CVV13SV
Molecule Type:
Small molecule
Molecular Formula:
C13H13IN2O2
Molecular Weight:
356.16
AlogP:
2.88
PSA:
44.12
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRIS(8-HYDROXYQUINOLINATO)GALLIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
R3G3HB38O4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LBS-008
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBS-008
×
Maximum Phase:
1
First Approval:
None
UNII:
63WI9S8P1M
Molecule Type:
Small molecule
Molecular Formula:
C21H21F5N4O2
Molecular Weight:
456.42
AlogP:
3.63
PSA:
69.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INZOMELID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INZOMELID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H24N4O3S
Molecular Weight:
388.49
AlogP:
2.95
PSA:
93.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AZD-5312
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-5312
×
Maximum Phase:
1
First Approval:
None
UNII:
3S31QX1Q6J
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIVAGABINE
1
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder
Unknown
PIVAGABINE
×
Maximum Phase:
1
First Approval:
None
UNII:
C53SV0WO4V
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO3
Molecular Weight:
187.24
AlogP:
1.01
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ARDENERMIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ARDENERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9B1I11GZRB
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEGLARINAD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TEGLARINAD
×
Maximum Phase:
1
First Approval:
None
UNII:
NUG9P5GWZB
Molecule Type:
Small molecule
Molecular Formula:
C30H43ClN5O8+
Molecular Weight:
637.15
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
NP031112
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NP031112
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-2018682
1
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Unknown
GSK-2018682
×
Maximum Phase:
1
First Approval:
None
UNII:
NJL503AIJA
Molecule Type:
Small molecule
Molecular Formula:
C22H21ClN4O4
Molecular Weight:
440.89
AlogP:
5.06
PSA:
103.27
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD5099
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD5099
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CPI-1205
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CPI-1205
×
Maximum Phase:
1
First Approval:
None
UNII:
455J2479FY
Molecule Type:
Small molecule
Molecular Formula:
C27H33F3N4O3
Molecular Weight:
518.58
AlogP:
4.72
PSA:
79.36
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ABT 737
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
ABT 737
×
Maximum Phase:
1
First Approval:
None
UNII:
Z5NFR173NV
Molecule Type:
Small molecule
Molecular Formula:
C42H45ClN6O5S2
Molecular Weight:
813.45
AlogP:
7.88
PSA:
128.13
HBD:
2.0
HBA:
#RotB:
16.0
Source:
BI 639667
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 639667
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN5O3S
Molecular Weight:
451.48
AlogP:
2.78
PSA:
106.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
106
107
108
109
110
111
112
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA